NCT03547609 (MEM-K) is a NA clinical trial of No arm intervention in Kabuki Syndrome, sponsored by University Hospital, Montpellier.

Who is sponsoring NCT03547609?

NCT03547609 is sponsored by University Hospital, Montpellier.

What drugs are being tested in NCT03547609?

Interventions in NCT03547609: No arm intervention.

What condition does NCT03547609 study?

NCT03547609 studies Kabuki Syndrome.

Is NCT03547609 still recruiting?

NCT03547609 is currently completed. Last updated 3 December 2018.

Last reviewed 2018-12-03 · How we verify

NCT03547609: MEM-K

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of Memory in Children With Kabuki Syndrom

Completed NA Last updated 3 December 2018

What this trial tests

NA trial testing No arm intervention in Kabuki Syndrome in 25 participants. Completed in 7 September 2018.

Timeline

8 June 2018

Primary endpoint
7 September 2018

7 September 2018

Quick facts

Lead sponsor	University Hospital, Montpellier
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	25
Start date	8 June 2018
Primary completion	7 September 2018
Estimated completion	7 September 2018
Sites	1 location across France

Drugs / interventions tested

No arm intervention

Conditions studied

Kabuki Syndrome — all drugs for Kabuki Syndrome →

Sponsor

University Hospital, Montpellier

Who can join

Adults 6 to 16, any sex, with Kabuki Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Mnesic function has not, at present, been evaluated in patients with Kabuki Syndrome. Some data from the neuroimagery suggest an impairment of memory function. The objective of our study is to assess the mnesic function of children with Kabuki Syndrom.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Montpellier trials

Trials by the same sponsor.

NCT07524127 — Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Pol · NA · not yet recruiting
NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
NCT07534189 — Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis · NA · not yet recruiting
NCT07515638 — Immun4Cure Cohort of Autoimmune Diseases · not yet recruiting
NCT07406516 — Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03547609 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Montpellier
Last refreshed: 3 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03547609.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing